Active Biotech wins Japan patent for laquinimod eye-drop formulation until 2042
Active Biotech secured a Japan patent for an ophthalmic laquinimod formulation, granting potential exclusivity in Japan until 2042 under patent number 7,918,190.
Active Biotech secured a Japan patent for an ophthalmic laquinimod formulation, granting potential exclusivity in Japan until 2042 under patent number 7,918,190.